Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases. The company conducts experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.